logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Monitor For Signs Of Decreased Venous Circulation In Affected Extremity Eg Increased Extremity Circumference Painful Swelling And Tenderness Pain Worsening In Dependent Position Pain Persisting With Extremity Use Palpable Hard Vein Enlargement Of The Superficial Veins Severe Cramping Redness And Warmth Numbness And Tingling Discoloration Of Skin Fever

    Medications for Monitor For Signs Of Decreased Venous Circulation In Affected Extremity Eg Increased Extremity Circumference Painful Swelling And Tenderness Pain Worsening In Dependent Position Pain Persisting With Extremity Use Palpable Hard Vein Enlargement Of The Superficial Veins Severe Cramping Redness And Warmth Numbness And Tingling Discoloration Of Skin Fever

    FiltersReset Filters
    11 results

    • butrans

      (buprenorphine)
      Purdue Pharma LP
      Usage: BUTRANS is indicated for managing severe, persistent pain requiring long-term opioid therapy when alternative treatments are inadequate. It should be used cautiously due to risks of addiction and overdose, and is not intended for as-needed pain relief.

    • conzip

      (tramadol hydrochloride)
      Vertical Pharmaceuticals, LLC
      Usage: CONZIP is indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not intended for as-needed use and should be reserved for patients who have not responded to non-opioid analgesics or immediate-release opioids due to risks of addiction and overdose.

    • fentanyl transdermal

      (fentanyl transdermal)
      SpecGx LLC
      Usage: Fentanyl transdermal system is indicated for managing severe, persistent pain in opioid-tolerant patients requiring long-term opioid treatment when other options are inadequate. It is not intended for as-needed use and should be used with caution due to risks of addiction, abuse, and overdose.

    • methadone hydrochloride

      (Methadone Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Methadone Hydrochloride Oral Solution is indicated for managing severe, persistent pain requiring long-term opioid treatment when other options are inadequate. It is also used for detoxification and maintenance treatment of opioid addiction. Not intended for as-needed analgesic use due to addiction risks.

    • methadone hydrochloride

      (Methadone Hydrochloride)
      Aurolife Pharma, LLC
      Usage: Methadone Hydrochloride Tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when alternatives are inadequate. Additionally, they are used for detoxification and maintenance treatment of opioid addiction, alongside appropriate social and medical services. Not for as-needed analgesic use.

    • methadone hydrochloride

      (METHADONE HYDROCHLORIDE)
      SpecGx LLC
      Usage: Methadone hydrochloride oral solution is indicated for managing severe, persistent pain when alternative treatments are inadequate, and for detoxification and maintenance treatment of opioid addiction. It is not intended for as-needed analgesic use and comes with risks of addiction, abuse, and misuse.

    • methadone hydrochloride

      (Methadone Hydrochloride)
      Mylan Institutional LLC
      Usage: Methadone Hydrochloride Injection is indicated for managing severe, persistent pain requiring long-term opioid treatment when alternatives are inadequate. It is also used for temporary opioid dependence treatment in patients unable to take oral medications. However, it is not for as-needed pain relief or outpatient addiction treatment.

    • ms contin

      (morphine sulfate)
      Rhodes Pharmaceuticals L.P.
      Usage: MS CONTIN is indicated for the management of severe and persistent pain requiring long-term opioid therapy when alternative treatments are inadequate. It is not intended for as-needed use and should be reserved for patients where other options have failed, due to risks of addiction and overdose.

    • tramadol hydrochloride

      (TRAMADOL HYDROCHLORIDE)
      Sun Pharmaceutical Industries, Inc.
      Usage: Tramadol hydrochloride extended-release tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are inadequate. Due to risks of addiction and overdose, they should be reserved for specific patients not responding to other treatments and are not intended for as-needed use.

    • tramadol hydrochloride

      (TRAMADOL HYDROCHLORIDE)
      Sun Pharmaceutical Industries, Inc.
      Usage: Tramadol hydrochloride extended-release tablets are indicated for managing severe, persistent pain requiring prolonged opioid treatment when alternative options are inadequate. They are not recommended for as-needed use and should be reserved for patients where other treatments are ineffective or intolerable due to addiction and overdose risks.